Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation

Soroush Tahmasebi1,2, Seyed Mehdi Jafarnejad1,2, Ingrid S Tam1,2

  • 1Goodman Cancer Research Center, McGill University, Montreal, QC H3A 1A3, Canada.

Insights

Yin-yang 2 (YY2) controls mouse embryonic stem cell (mESC) self-renewal and differentiation. Its expression is regulated by translation inhibitors (4E-BPs) and splicing factor PTBP1, impacting pluripotency factors like Oct4.

Area of Science:

  • Developmental Biology
  • Gene Regulation
  • Stem Cell Biology

Background:

  • Translational control is crucial for early embryonic development.
  • Mouse embryonic stem cells (mESCs) rely on precise gene expression for self-renewal and differentiation.
  • Eukaryotic initiation factor 4E-binding proteins (4E-BPs) are key regulators of translation.

Purpose of the Study:

  • To identify and characterize novel regulators of mESC self-renewal and differentiation.
  • To elucidate the regulatory mechanisms controlling the expression of key pluripotency factors.
  • To investigate the role of translational control in mESC lineage commitment.

Main Methods:

  • Identification of Yin-yang 2 (YY2) as a transcriptional regulator in mESCs.
  • Analysis of YY2's regulation by 4E-BPs.
  • Investigation of YY2's role in controlling pluripotency factors (Oct4, Esrrb).
  • Assessment of YY2's effect on mESC differentiation into cardiovascular lineages.
  • Characterization of the role of Polypyrimidine tract-binding protein 1 (PTBP1) in Yy2 mRNA processing.

Main Results:

  • YY2 is a critical regulator of mESC self-renewal and pluripotency.
  • YY2 controls the expression of key pluripotency factors Oct4 and Esrrb.
  • Overexpression of YY2 induces differentiation of mESCs into cardiovascular lineages.
  • PTBP1-mediated intron retention in Yy2 mRNA confers 4E-BP-dependent translational suppression.
  • A multilayered regulatory mechanism controls YY2 expression.

Conclusions:

  • YY2 is a significant regulator of mESC self-renewal and lineage commitment.
  • A novel regulatory pathway involving 4E-BPs, PTBP1, and Yy2 mRNA splicing controls YY2 expression.
  • This study reveals a complex mechanism governing stem cell fate decisions through translational control.

Related Concept Videos

Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.7K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.1K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Zygotic Development And Stem Cell Formation01:10

Zygotic Development And Stem Cell Formation

The development of all multicellular organisms starts with the fusion of haploid cells called sperm and egg to form a diploid zygote. A zygote is a totipotent cell that can develop into a complete organism. The zygote undergoes cell division or cleavage to form an 8-cell mass. Until this stage, the cells are spherical, loosely attached, and remain totipotent. Totipotent cells are capable of developing both the embryonic and the extraembryonic tissues. However, as they continue to divide, they...
7.1K